Conversion of brain apolipoprotein E to an insoluble form in a mouse model of Alzheimer disease

Asha Naidu, Rosanne Catalano, Kelly Bales, Su Wu, Steven M. Paul, Barbara Cordell

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Aβ deposition in the APPv717F transgenic model of Alzheimer's pathology involves apolipoprotein E (apoE). We measured soluble and insoluble apoE in brain region extracts at an early and late stage of plaque development. The apoE levels in the insoluble fraction were greatly elevated in the hippocampus and cortex of aged transgenic animals but were unchanged in wild type or young APPv717F animals. Soluble apoE levels were unaltered. Aβ levels were also measured and a positive correlation between apoE and Aβ in the insoluble fraction was observed. ApoE transcription was increased ∼3-fold in the hippocampus of 17-month-old APPv717F mice, suggesting a region-specific upregulation of apoE transcription in the brains V717F of APP mice to compensate for apoE sequestered with fibrillar Aβ.

Original languageEnglish
Pages (from-to)1265-1270
Number of pages6
JournalNeuroReport
Volume12
Issue number6
DOIs
StatePublished - May 8 2001

Fingerprint

Dive into the research topics of 'Conversion of brain apolipoprotein E to an insoluble form in a mouse model of Alzheimer disease'. Together they form a unique fingerprint.

Cite this